Broad, Bayer expand partnership to develop therapies for cardiovascular disease
(Broad Institute of MIT and Harvard) The Broad Institute of MIT and Harvard have expanded their collaboration with Bayer HealthCare to include cardiovascular genomics and drug discovery. The goal of this new part of the alliance is to leverage insights from human genetics to help create new cardiovascular therapies. Read Full Article Here For more…